LMAT
LeMaitre Vascular, Inc.About LMAT
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Company
- Headquarters
- Burlington, MA
- Employees
- 655 (2026)
- Listed
- Oct 19, 2006
- Exchange
- Nasdaq
- Website
- lemaitre.com
- SEC industry
- Surgical & Medical Instruments & Apparatus
- Cylvex sector
- Health Care · Medical Devices
Medical Devices
- Market cap #41 of 163
- P/B #59 of 152
Ranked highest first among stocks Cylvex covers.
- ABTAbbott Laboratories$199.9B+5.62%
- ISRGIntuitive Surgical Inc$170.4B+9.41%
- MDTMedtronic plc$134.3B+6.19%
- SYKStryker Corporation$130.4B+9.44%
- BSXBoston Scientific Corp.$66.40B+5.32%
Financial summary
Related companies
About
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
From company filings and market data · Not investment advice
Price data
From daily bars
Financials
Consensus estimates
The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.